User login
For women with cervical cytology results showing atypical squamous cell of undetermined significance (ASCUS) and positive results on DNA testing of a cervical sample for human papillomavirus (HPV) high-risk types, about 1 out of 8 progress to cervical intraepithelial neoplasia (CIN) grades 2 or 3 within 2 years of initial colposcopy results showing not more than CIN 1. Since women with cytology results of lowgrade squamous intraepithelial lesion (LSIL) progress to CIN 2 or 3 in the same proportion, management protocols for HPV-positive ASCUS and LSIL should be identical.
For women with cervical cytology results showing atypical squamous cell of undetermined significance (ASCUS) and positive results on DNA testing of a cervical sample for human papillomavirus (HPV) high-risk types, about 1 out of 8 progress to cervical intraepithelial neoplasia (CIN) grades 2 or 3 within 2 years of initial colposcopy results showing not more than CIN 1. Since women with cytology results of lowgrade squamous intraepithelial lesion (LSIL) progress to CIN 2 or 3 in the same proportion, management protocols for HPV-positive ASCUS and LSIL should be identical.
For women with cervical cytology results showing atypical squamous cell of undetermined significance (ASCUS) and positive results on DNA testing of a cervical sample for human papillomavirus (HPV) high-risk types, about 1 out of 8 progress to cervical intraepithelial neoplasia (CIN) grades 2 or 3 within 2 years of initial colposcopy results showing not more than CIN 1. Since women with cytology results of lowgrade squamous intraepithelial lesion (LSIL) progress to CIN 2 or 3 in the same proportion, management protocols for HPV-positive ASCUS and LSIL should be identical.